# Eric L. Simpson

**Type:** Researchers  
**Canonical URL:** https://picoportal.org/library/researchers/eric-l-simpson/

## Facts

| Field | Value |
| --- | --- |
| Citations | 23,555 |
| Field | Dermatology and Skin Diseases |
| h-index | 76 |
| i10-index | 207 |
| Last Known Institution | Oregon Health & Science University |
| OpenAlex ID | https://openalex.org/A5015905197 |
| ORCID iD | https://orcid.org/0000-0003-0853-0252 |
| Works | 553 |

## Researcher papers

Showing 12 of 19.

- [Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis](https://picoportal.org/library/papers/two-phase-3-trials-of-dupilumab-versus-placebo-in-atopic-dermatitis/)
- [Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)*](https://picoportal.org/library/papers/tralokinumab-for-moderate-to-severe-atopic-dermatitis-results-from-two-52-week/)
- [Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults](https://picoportal.org/library/papers/efficacy-and-safety-of-crisaborole-ointment-a-novel-nonsteroidal/)
- [Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials](https://picoportal.org/library/papers/once-daily-upadacitinib-versus-placebo-in-adolescents-and-adults-with-moderate/)
- [Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis](https://picoportal.org/library/papers/efficacy-and-safety-of-dupilumab-in-adolescents-with-uncontrolled-moderate-to/)
- [Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial](https://picoportal.org/library/papers/efficacy-and-safety-of-abrocitinib-in-adults-and-adolescents-with-moderate-to/)
- [Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis](https://picoportal.org/library/papers/efficacy-and-safety-of-upadacitinib-vs-dupilumab-in-adults-with-moderate-to/)
- [Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis](https://picoportal.org/library/papers/abrocitinib-versus-placebo-or-dupilumab-for-atopic-dermatitis/)
- [Atopic dermatitis in the pediatric population](https://picoportal.org/library/papers/atopic-dermatitis-in-the-pediatric-population/)
- [Conjunctivitis in dupilumab clinical trials](https://picoportal.org/library/papers/conjunctivitis-in-dupilumab-clinical-trials/)
- [Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis](https://picoportal.org/library/papers/efficacy-and-safety-of-abrocitinib-in-patients-with-moderate-to-severe-atopic/)
- [Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis](https://picoportal.org/library/papers/two-phase-3-trials-of-lebrikizumab-for-moderate-to-severe-atopic-dermatitis/)

## Researcher topics

- [Dermatology and Skin Diseases](https://picoportal.org/library/topics/dermatology-and-skin-diseases/)
- [Allergic Rhinitis and Sensitization](https://picoportal.org/library/topics/allergic-rhinitis-and-sensitization/)
- [Asthma and respiratory diseases](https://picoportal.org/library/topics/asthma-and-respiratory-diseases/)
- [Food Allergy and Anaphylaxis Research](https://picoportal.org/library/topics/food-allergy-and-anaphylaxis-research/)
- [Psoriasis: Treatment and Pathogenesis](https://picoportal.org/library/topics/psoriasis-treatment-and-pathogenesis/)

## Researcher university

- [Oregon Health & Science University](https://picoportal.org/library/institutions/oregon-health-and-science-university/)

---
Source: PICO Portal — public research metadata, principally OpenAlex. See https://picoportal.org/library/sources/ for provenance and https://picoportal.org/library/methodology/ for what these figures mean.